Nutex Health (FRA:5LF) Total Debt per Share: €44.05 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:5LF Nutex Health Inc FRA:5LF
57 GF Score
Price €165.00
GF Value €70.29
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Nutex Health Total Debt per Share?

Nutex Health FRA:5LF +3.77% 57 Total Debt per Share is €44.05 as of Jun. 2026. GuruFocus rates FRA:5LF with a GF Score™ of 57/100 and a GF Value™ of €70.29 (Significantly Overvalued). The stock has 6 warning signs investors should review.

€44.05 (As of Jun. 2026)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Nutex Health's Total Debt Per Share for the quarter that ended in Jun. 2026 was €44.05.


Nutex Health Total Debt per Share Historical Data

* Premium members only.

The historical data trend for Nutex Health's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nutex Health Total Debt per Share Chart

Nutex Health Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Debt per Share
Get a 7-Day Free Trial 36.82 58.19 56.06 58.97 42.34

Nutex Health Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Debt per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 45.39 44.25 42.34 43.44 44.05
FRA:5LF
57GF Score
Nutex Health Inc FRA:5LF
Total Debt per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nutex Health Total Debt per Share Calculation

Nutex Health's Total Debt Per Share for the fiscal year that ended in Dec. 2025 is calculated as:

Nutex Health's Total Debt Per Share for the quarter that ended in Jun. 2026 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Debt per Share →
What does a Total Debt per Share of €44.05 mean?
Nutex Health (FRA:5LF) has a Total Debt per Share of €44.05 as of Jun. 2026. Total debt per share equals the per-share value of a company's long-term and short-term debt. View historical data on Nutex Health and its competitors.
Is Nutex Health's Total Debt per Share too high?
Nutex Health's current Total Debt per Share is €44.05. Overall, Nutex Health has a GF Score™ of 57/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Nutex Health's Total Debt per Share compare to USPH and AMN?
Nutex Health's Total Debt per Share of €44.05 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Debt per Share for a Healthcare Providers & Services company?
A good Total Debt per Share depends on the Healthcare Providers & Services industry context. However, Total Debt per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Debt per Share mean?
A high Total Debt per Share can signal that a stock is expensive relative to its fundamentals. Total debt per share equals the per-share value of a company's long-term and short-term debt. View historical data on Nutex Health and its competitors. Nutex Health's current Total Debt per Share is €44.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nutex Health stock overvalued right now?
Based on GuruFocus' analysis, Nutex Health (FRA:5LF) is currently considered Significantly Overvalued. The stock's GF Value™ is €70.29, compared to a current price of €165.00 — trading 134.7% above its estimated fair value. The current Total Debt per Share is €44.05. Nutex Health's overall GF Score™ is 57/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Debt per Share calculated?
Total Debt per Share is calculated from a company's financial statements. For Nutex Health (FRA:5LF), the current Total Debt per Share is €44.05 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nutex Health (FRA:5LF) Overvalued in 2026?

Based on GuruFocus' analysis, Nutex Health stock appears to be overvalued. The current stock price of €165.00 is trading 134.7% above its estimated GF Value™ of €70.29. GuruFocus considers Nutex Health to be Significantly Overvalued.

Key valuation signals for FRA:5LF:

  • Total Debt per Share: €44.05
  • GF Value™: €70.29 vs. price of €165.00 (134.7% above fair value)
  • GF Score™: 57/100 with 6 warning signs

No single metric tells the full story. See the FRA:5LF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Nutex Health Business Description

Other Exchanges NUTX:USA
Address 1776 Yorktown Street, Suite 700, Houston, TX, USA, 77056
Nutex Health Inc is a physician-led, healthcare services and operations company with various hospital facilities in the U.S. states (hospital division), and a primary care-centric, risk-bearing population health management division. The company has three segments: the hospital division, the PHM division, and the real estate division. The hospital division implements and operates health care models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management (PHM) division owns and operates provider networks such as independent physician associations (IPAs). The Real Estate Entities own the land and hospital buildings which are leased to its hospital entities. The majority of the revenue is derived from the Hospital division.
57GF Score

Get the complete analysis for FRA:5LF

Total Debt per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€165.00
Price
€70.29
GF Value